ÇETİNARSLAN, T. Et Al. 2025. Oral administration of ruxolitinib in psoriasis vulgaris: A case report of plaque psoriasis accompanied by myelofibrosis secondary to polisitemia vera successfully treated with oral ruxolitinib. Journal of Dermatology , vol.52, no.1 , 179-182.

ÇETİNARSLAN, T., Aydoğdu, İ., & Ermertcan, A. T., (2025). Oral administration of ruxolitinib in psoriasis vulgaris: A case report of plaque psoriasis accompanied by myelofibrosis secondary to polisitemia vera successfully treated with oral ruxolitinib. Journal of Dermatology , vol.52, no.1, 179-182.

ÇETİNARSLAN, TUBANUR, İSMET AYDOĞDU, And Aylin Türel Ermertcan. "Oral administration of ruxolitinib in psoriasis vulgaris: A case report of plaque psoriasis accompanied by myelofibrosis secondary to polisitemia vera successfully treated with oral ruxolitinib," Journal of Dermatology , vol.52, no.1, 179-182, 2025

ÇETİNARSLAN, TUBANUR Et Al. "Oral administration of ruxolitinib in psoriasis vulgaris: A case report of plaque psoriasis accompanied by myelofibrosis secondary to polisitemia vera successfully treated with oral ruxolitinib." Journal of Dermatology , vol.52, no.1, pp.179-182, 2025

ÇETİNARSLAN, T. Aydoğdu, İ. And Ermertcan, A. T. (2025) . "Oral administration of ruxolitinib in psoriasis vulgaris: A case report of plaque psoriasis accompanied by myelofibrosis secondary to polisitemia vera successfully treated with oral ruxolitinib." Journal of Dermatology , vol.52, no.1, pp.179-182.

@article{article, author={TUBANUR ÇETİNARSLAN Et Al. }, title={Oral administration of ruxolitinib in psoriasis vulgaris: A case report of plaque psoriasis accompanied by myelofibrosis secondary to polisitemia vera successfully treated with oral ruxolitinib}, journal={Journal of Dermatology}, year=2025, pages={179-182} }